BioMarin (BMRN)
Develops rare-disease medicines across enzyme therapies, metabolic disorders, and skeletal conditions.
$63.88
vs last close−0.18 (−0.28%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 101.44% | 196.36M shares | |
|---|---|---|---|
| 587 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.53% | 1.02M shares | |
| 19 holders · as of Sep 14, 2026 | |||
| Adds to | 101.97% | ||
193.57M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 101.97%; nothing is left for Other.
13F, as of Jun 30, 2026
587 holders · 196.36M shares · 88 new positions · 293 increased · 198 reduced · 83 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 20.45M | 10.56% | +626.9K | Aug 7, 2026 |
| Dodge & Cox | 14.84M | 7.67% | +283.2K | Aug 13, 2026 |
| Primecap Management Co/CA/ | 14.19M | 7.33% | −3.8K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 8.74M | 4.52% | +100.5K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 8.65M | 4.47% | +350.2K | Aug 13, 2026 |
| Norges Bank | 8.21M | 4.24% | +8.21Mnew | Aug 12, 2026 |
| State Street Corp | 7.80M | 4.03% | +505.9K | Aug 7, 2026 |
| Viking Global Investors LP | 7.62M | 3.93% | +554.5K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 9.10% | 17.56M | 13G | Jan 21, 2026 |
| Primecap Management Co/CA/ | 8.24% | 15.80M | 13G | Aug 14, 2025 |
| Vanguard Capital Management | 5.25% | 10.11M | 13G | Apr 29, 2026 |
| Viking Global Investors LPincl. Viking Long Fund Master Ltd., Viking Global Equities Master Ltd. +10 more | 5.10% | 9.75M | 13G | Sep 30, 2024 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 2, 2026 | George Eric Davisofficer: EVP, Chief Legal Officer | Sale | 17,557 | $66.28 | 61,003 |
| May 7, 2026 | Gregory R. Fribergofficer: EVP, Chief R&D Officer | Sale | 3,281 | $53.85 | 51,818 |
| Mar 11, 2026 | Charles Greg Guyerofficer: EVP, Chief Technical Officer | Sale | 16,486 | $60.46 | 79,953 |
| Feb 26, 2026 | George Eric Davisofficer: EVP, Chief Legal Officer | Sale | 26,061 | $61.36 | 72,453 |
| Feb 26, 2026 | Gregory R. Fribergofficer: EVP, Chief R&D Officer | Sale | 6,326 | $60.38 | 37,578 |
House and Senate disclosures
Not reported.